BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Kurimoto N, Inagaki T, Aoki T, Kadotani H, Kurimoto F, Kuriyama K, Yamada N, Ozeki Y. Factors causing a relapse of major depressive disorders following successful electroconvulsive therapy: A retrospective cohort study. World J Psychiatr 2021; 11(10): 841-853 [PMID: 34733646 DOI: 10.5498/wjp.v11.i10.841]
URL: https://www.wjgnet.com/2220-3206/full/v11/i10/841.htm
Number Citing Articles
1
Octavian Vasiliu. Efficacy, Tolerability, and Safety of Toludesvenlafaxine for the Treatment of Major Depressive Disorder—A Narrative ReviewPharmaceuticals 2023; 16(3): 411 doi: 10.3390/ph16030411
2
Gopalkumar Rakesh, Patrick Cordero, Rebika Khanal, Seth S. Himelhoch, Craig R. Rush. Optimally combining transcranial magnetic stimulation with antidepressants in major depressive disorder: A systematic review and Meta-analysisJournal of Affective Disorders 2024; 358: 432 doi: 10.1016/j.jad.2024.05.037
3
Akise Umakoshi, Masahiro Takeshima, Yu Itoh, Mari Yamamoto, Nana Shibata, Masaya Ogasawara, Naoko Ayabe, Kazuo Mishima. Relationship among psychotic features, benzodiazepine receptor agonists, and rehospitalization in patients with electroconvulsive therapy‐responsive major depressive disorder: A retrospective 2‐year observational studyNeuropsychopharmacology Reports 2022; 42(4): 449 doi: 10.1002/npr2.12282